Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.46 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.44 |
| ▸ | MYLK4 | Q86YV6 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18382129 | 1.00 | KMT2A (0.58) | KMT2AESR1ESR2MEN1GABBR2 | |
| SCHEMBL18382201 | 1.00 | KMT2A (0.58) | KMT2AESR1ESR2MEN1GABBR2 | |
| Hydrochloric Acid SCHEMBL114327 | 0.98 | KMT2A (0.56) | KMT2AESR1ESR2MEN1GABBR2 | |
| Hydrochloric Acid SCHEMBL3999039 | 0.89 | CHRNB2 (0.47) | KMT2AESR1ESR2ALDH1A1PTGS2 | |
| SCHEMBL27406112 | 0.86 | CTSS (0.49) | KMT2AMEN1PTGS1PTGS2 | |
| SCHEMBL1094245 | 0.86 | KMT2A (0.55) | KMT2AESR1ESR2MEN1TSHR | |
| Hydrochloric Acid SCHEMBL1092749 | 0.84 | KMT2A (0.53) | KMT2AESR1ESR2MEN1TSHR | |
| SCHEMBL8912908 | 0.84 | MMP8 (0.53) | KMT2AMEN1GABBR2GABBR1TSHR | |
| SCHEMBL8912131 | 0.84 | ESR1 (0.68) | ESR1ESR2TSHRTAAR1 | |
| SCHEMBL512129 | 0.84 | MMP8 (0.53) | KMT2AMEN1GABBR2GABBR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638538-A | Cleanup additive for oilfield acidizing and fracturing and preparation method thereof | 寿光新海能源技术有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-117700643-A | Polycarboxylate superplasticizer and preparation method thereof | 科之杰新材料集团有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-117700642-A | Dispersed polycarboxylate superplasticizer and preparation method thereof | 科之杰新材料集团有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20230019129-A1 | HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2023-01-19 | — | — | US | disclosed |
| EP-3974426-A1 | HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS | Indiana University Research and Technology Corporation (US) | 2022-03-30 | — | — | EP | disclosed |
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | CTXT PTY LIMITED (AU) | 2021-12-09 | — | — | US | disclosed |
| US-20210363141-A1 | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE | ALCON INC. (CH) | 2021-11-25 | — | — | US | disclosed |
| US-11136296-B2 | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2021-10-05 | — | — | US | disclosed |
| CN-109097117-B | Energy-saving and environment-friendly gasoline combustion improver and preparation method thereof | 北京燧火科技有限公司 | 2021-07-06 | — | — | CN | disclosed |
| US-11028081-B2 | Dual mechanism inhibitors for the treatment of disease | AERIE PHARMACEUTICALS, INC. (US) | 2021-06-08 | — | — | US | disclosed |
| CN-1262270-A | Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide | ROHM & HAAS (US) | 2000-08-09 | — | — | CN | disclosed |
| CN-1262269-A | Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide | ROHM & HAAS (US) | 2000-08-09 | — | — | CN | disclosed |
| CN-1216943-A | Method of cleaning carpets | PROCTER & GAMBLE (US) | 1999-05-19 | — | — | CN | disclosed |
| CN-1215329-A | Personal cleansing bar compositions containing perfume releasing complexes | PROCTER & GAMBLE (US) | 1999-04-28 | — | — | CN | disclosed |
| CN-1206401-A | Process for preparing 2-(2-methylphenyl)-3-methoxyacrylic acid methylester | BASF AG (DE) | 1999-01-27 | — | — | CN | disclosed |
| CN-1204637-A | Benzyloxy substituted aromatics and their use as fungicides and insecticides | ROHM & HAAS (US) | 1999-01-13 | — | — | CN | disclosed |
| CN-1175575-A | Benzyloxy substituted aromatics and their use as fungicides and insecticides | ROHM & HAAS (US) | 1998-03-11 | — | — | CN | disclosed |
| CN-1171392-A | Benzyloxy substitutedaromatics and their use as fungicides and insecticides | ROHM & HAAS (US) | 1998-01-28 | — | — | CN | disclosed |
| CN-1143637-A | Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides | ROHM & HAAS (US) | 1997-02-26 | — | — | CN | disclosed |
| CN-1128758-A | Pyridazinone and application as fungicide | ROHM & HAAS (US) | 1996-08-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | KAT5, KAT6A, KAT2A | KMT2A 86/4885ESR1 4769/4885ESR2 3977/4885 |
| US-11136296-B2 | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof | AADAC, NAT1, EPX | KMT2A 921/4885ESR1 3276/4885ESR2 340/4885 |
| US-20230019129-A1 | HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS | HAVCR2, MAVS, FABP1 | KMT2A 3024/4885ESR1 1817/4885ESR2 1478/4885 |
| US-11028081-B2 | Dual mechanism inhibitors for the treatment of disease | RHOA, SLC6A2, ROCK2 | KMT2A 3013/4885ESR1 4179/4885ESR2 2466/4885 |
| US-20210363141-A1 | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE | RHOA, SLC6A2, ROCK2 | KMT2A 3013/4885ESR1 4179/4885ESR2 2466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.